NEW YORK, July 1 (Reuters) – A U.S. jury on Friday awarded
$70 million to the family of a boy who developed breasts after
taking Johnson & Johnson unit Janssen Pharmaceuticals’
antipsychotic drug…
The post UPDATE 1-J&J’s Janssen hit with $70 mln verdict in Risperdal trial appeared first on NASDAQ.